Table 1. Patient demographics.
Factors | Sirolimus group (n=28) |
Control group (n=69) |
P value |
---|---|---|---|
Recipient factors | |||
Age (yr) | 47.71±9.01 | 44.94±10.76 | 0.232 |
Male recipients | 12 (42.9%) | 38 (55.1%) | 0.275 |
Donor factors | |||
Deceased donor | 4 (14.3%) | 33 (47.8%) | 0.002 |
Donor age (yr) | 44.96±10.90 | 43.43±12.31 | 0.569 |
Male donors | 12 (42.9%) | 35 (50.7%) | 0.482 |
Immunologic factors | |||
Previous renal transplant | 6 (21.4%) | 8 (11.6%) | 0.219 |
High PRA | 14 (50.0%) | 27 (39.1%) | 0.326 |
HLA-mismatch | 3.89±1.45 | 3.59±1.44 | 0.357 |
A | 1.07±0.72 | 1.03±0.69 | 0.786 |
B | 1.43±0.63 | 1.46±0.68 | 0.814 |
DR | 1.39±0.57 | 1.10±0.67 | 0.045 |
Total HLA mismatch ≥4 | 18 (64.3%) | 50 (72.5%) | 0.425 |
PRA, panel reactive antibody; HLA, human leukocyte antigen.